Common questions about Визанна (FAQ)
Q: What condition is Визанна specifically approved to treat?
Official regulatory documents state that Visanne is indicated for the management of pelvic pain associated with endometriosis. This is the specific condition for which the medication has received approval from health authorities.
Q: How is Визанна different from combination birth control pills used for endometriosis?
Visanne is classified as a standalone progestin medication, containing only the active ingredient, dienogest. In contrast, combination pills used for endometriosis contain both estrogen and a progestin. This difference in composition means they affect the body's hormonal balance differently.
Q: Is Визанна considered a type of progestin-only medication?
Yes, the active component of Visanne, dienogest, is a synthetic hormone belonging to the progestin group. Regulatory documents categorize this formulation as a progestin-only medication, as it does not include estrogen.
Q: What are the most common side effects reported in studies of Визанна?
Official data indicates that the most common reported side effects include headache, breast discomfort, mood changes, and weight gain. It is also common to experience changes in bleeding patterns, such as irregular uterine or vaginal bleeding, including spotting.
Q: Is it common to experience weight gain while taking Визанна?
Weight gain is listed in the official product information as a common side effect of Visanne, potentially affecting up to 1 in 10 users. However, individual responses vary, and not all patients experience this side effect.
Q: Does Визанна cause mood changes or feelings of depression?
Regulatory documents list depressed mood, mood changes, and nervousness as common side effects of Visanne. These emotional changes are noted in the official product information due to the hormonal effects of the medication.
Q: Is there a documented connection between Визанна and the risk of blood clots?
Regulatory information suggests that progestin-only medications might carry a slightly higher risk of blood clots (thromboembolism). Studies are not certain about the magnitude of this risk.
Q: Can Визанна cause hair loss or acne to develop?
Both acne and hair loss (alopecia) are listed in official product information as common side effects of Visanne. These effects are generally observed in up to 1 in 10 people taking the medication.
Q: What information is available about Визанна and bone mineral density in adolescents?
Regulatory documents indicate that Visanne can cause a decrease in bone mineral density (BMD) in adolescents (girls aged 12 to <18). Because of this potential effect, the official prescribing information outlines the need for regular review of the risks and benefits of use in this age group.
Q: Are there known risks for women who have a prior history of depression?
If a patient has a prior history of depression, regulatory information suggests that conditions like a prior history of depression are factors for consideration during treatment with Visanne. This precaution is noted because hormonal medications have the potential to cause mood changes.
Q: What are the signs of a serious side effect that requires immediate medical attention?
Official product information describes warning signs that warrant prompt medical review, including symptoms of a blood clot, such as severe chest pain, sudden difficulty breathing, or severe swelling in a limb. Symptoms of liver problems, such as yellowing of the skin or eyes (jaundice) or dark urine, are also described as signs that warrant medical review.
Q: What do studies indicate about the risk of breast cancer while taking Визанна?
Official regulatory information lists a diagnosis of breast cancer or other hormone-dependent malignancies as a contraindication for using Visanne. This means that the use of the medication is officially restricted in patients with these conditions.
Q: Is it common to have hot flashes while on Визанна therapy?
Hot flushes (or hot flashes) are included in the official lists of common side effects associated with Visanne therapy. This is a recognized hormonal effect of the treatment.
Q: Is Визанна considered a method of birth control?
No, Visanne is not approved or considered a method of birth control. Official consumer information states clearly that it will not prevent pregnancy.
Q: What non-hormonal birth control methods are acceptable to use while taking Визанна?
Official documentation specifies that a nonhormonal barrier method of birth control, such as condoms or a diaphragm, should be used while taking Visanne. The product information states that the use of any hormonal contraceptives should be avoided during treatment.
Q: What should be done if a patient becomes pregnant while taking Визанна?
Visanne is contraindicated in pregnancy. Official instructions indicate that the use of the medication must be discontinued if pregnancy occurs or is suspected.
Q: How long is the maximum duration a patient can take Визанна continuously, according to research data?
Official clinical studies used for regulatory approval tested the efficacy and safety of Visanne for a duration of up to 15 months. Use beyond this studied duration requires professional assessment of the patient's individual situation.
Q: Does Визанна cause menstrual periods to stop completely (amenorrhea)?
Changes in vaginal bleeding patterns are common, and official product information notes that the complete stoppage of menstrual periods (amenorrhea) is a possible side effect of Visanne.
Q: Is experiencing spotting or irregular bleeding common during the first few months on Визанна?
Uterine or vaginal bleeding, including breakthrough bleeding or spotting, is a common side effect. Regulatory sources indicate that these irregular bleeding patterns are most likely to occur during the first few months of starting treatment.
Q: What should be done if heavy or continuous bleeding occurs while taking Визанна?
While some abnormal bleeding is expected, official information advises that unexpected, heavy, or continuous vaginal bleeding are factors that warrant consultation with a healthcare professional.
Q: Are there any herbal supplements or vitamins known to interact with Визанна?
St. John's wort is the specific herbal supplement listed in regulatory documents as potentially interacting with Visanne. Because it can reduce the concentration of the drug in the body, its potential interaction is a factor for professional discussion.
Q: Does grapefruit juice interact with Визанна and increase the risk of side effects?
Grapefruit juice is listed in the official interaction information as a food product that may interact with Visanne. Regulatory documents suggest that consumption of grapefruit juice could lead to increased concentrations of the drug in the body, which may affect side effects.
Q: What is the official information regarding Визанна and cigarette smoking?
Regulatory warnings cite cigarette smoking as a known risk factor for developing blood clots (thromboembolism). This potential risk makes the patient's smoking status a required factor for professional review before use.
Q: Can women with a history of liver disease use Визанна?
Official prescribing information lists active or clinically significant liver disease as a contraindication. This means the use of the medication is restricted for patients who have conditions such as liver tumors or severe liver impairment.
Q: What precautions should be taken if surgery is scheduled while on Визанна?
Due to the increased risk of blood clots from prolonged immobilization, this medication may need to be stopped before certain types of major surgery. This requirement makes advance professional consultation necessary before any scheduled procedure.
